Venture Capital

Updated:

S-Ventures PLC

S-Ventures PLC is a publicly listed investment business that identifies opportunities in health and wellness, consumer tech, security and AI.

S-Ventures PLC logo

S-Ventures PLC

S-Ventures PLC is a publicly listed investment business that identifies opportunities in health and wellness, consumer tech, security and AI. It aims to add capital and expertise to target companies through smaller asymmetric investments that offer investor liquidity, seeking dividend earnings as well as outlier returns on capital. It currently holds a material stake in AIM-listed TOORU PLC from the sale of previous investments.

General information

Firm type

Venture Capital

Year founded

2020

Location

Region

Europe

Country

United Kingdom

City

London

Corporate office

London, United Kingdom

Principals

Scott Paul Livingston (Chief Executive Officer)

Bhanu Choudhrie (Non-Executive Director)

Amelia Fuggle (Secretary)

Richard Bohan (Secretary)

Sector focus

Consumer Goods

Frequently asked questions

Why did S-Ventures delist from the Aquis Stock Exchange?

In April 2024, the company announced its intention to delist and re-register as a private limited company. The board cited the ongoing costs and administrative burden of maintaining a public listing as disproportionate to the firm's current size and strategic needs. Trading liquidity on the Aquis Stock Exchange had been limited, reducing the benefits of public-market access.

Does S-Ventures operate as a fund or a holding company?

S-Ventures operates as an operating holding company, acquiring and managing a portfolio of consumer brand subsidiaries directly on its balance sheet. It does not manage third-party capital through a traditional fund structure. Following its delisting in 2024, the firm simplified its governance to a private limited-company model.

What sectors does S-Ventures target?

The firm targets consumer wellness categories, including plant-based foods, functional beverages, natural health supplements, and personal care products. Its thesis is built on acquiring brands that benefit from the long-term consumer shift toward health-conscious purchasing, with a distribution footprint spanning retail and direct-to-consumer channels in the UK and Europe.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More London Venture Capital profiles